相关实验视频

Updated: Jun 29, 2025

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes

Published on: July 18, 2008

来自哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥哥

Ellen Hertz^1,2, Gani Perez^1,2, Ying Hao³

¹Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.

bioRxiv : the preprint server for biology

|March 26, 2024

概括

我们开发了一种从诱导多能干细胞 (iPSCs) 中丰富多巴胺基 (DA) 神经元的方法,以研究高氏病 (GD) 和帕金森病 (PD). 这种方法揭示了基因修饰剂可能解释GD患者的PD异调.

科学领域:

神经科学是一个神经科学.
干细胞生物学干细胞生物学
遗传学遗传学是一个

背景情况:

诱导性多能干细胞 (iPSC) 对于模拟像帕金森病 (PD) 这样的神经疾病至关重要.
研究与GBA1突变相关的PD家族形式需要疾病相关的细胞模型.
在iPSC差异化效率的异质性使比较研究复杂化.

研究的目的:

开发一种选择策略,用于从iPSC中丰富多巴胺基 (DA) 神经元,用于疾病建模.
利用同源细胞系研究导致GBA1相关帕金森症的基因修饰剂.
为了比较患有Gaucher病 (GD) 的人的DA神经元与PD不一致.

主要方法:

在氨酸氧化酶 (TH) 基因基因位点中插入一种新菌素耐药性基因 (neo) 来进行基因素选择.
从三个姐妹的iPSC线 (健康,GD,PD的GD) 中生成高纯度TH+DA神经元培养物.
对差异化DA神经元中的GCase蛋白水平和脂质基质积累的全面分析.

主要成果:

一种新的选择策略成功丰富了TH + DA神经元,使不同iPSC线的可比培养成为可能.
来自高氏病 (GD) 患者的DA神经元显示了降低的葡萄糖大脑酶 (GCase) 水平.
在GD和GD/PD患者衍生的DA神经元之间没有观察到GCase水平或脂质积累的显著差异,这表明其他遗传因素会影响PD的发展.

结论:

开发的TH驱动的遗传素选择方法为疾病建模提供高纯度的DA神经元培养物.
氏病的DA神经元表现出降低的GCase,但仅此并不能解释PD的发展.
在GBA1突变的兄弟姐妹中,PD发展的不一致性突出了帕金森症中额外的遗传修饰剂的作用.

关键词:

在 GBA1 中,GBA1 是 GBA1 的代名词.戈舍氏病是戈舍氏病的一种疾病.帕金森病是帕金森病的一种疾病.多巴胺作用的神经元分化.这就是 iPSC 的意义.尼奥米辛的耐药性耐药性神经退行症的神经退行症

更多相关视频

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...